Stocks TelegraphStocks Telegraph
Stock Ideas

AXSM Financial Statements and Analysis

NASDAQ : AXSM

Axsome Therapeutics, Inc.

$112.98
0.06+0.05%
Open: 9:56 AM
58.16
BESG ScoreESG Rating

AXSM FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

AXSM Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue104.762M87.166M74.999M71.53M57.794M
cost of revenue8.437M8.055M8.128M7.378M6.532M
gross profit96.325M79.111M66.871M64.152M51.262M
gross profit ratio0.9190.9080.8920.8970.887
research and development expenses45.388M49.853M36.588M30.803M28.767M
general and administrative expenses073.254M74.97M62.709M55.088M
selling and marketing expenses030.30M24.00M24.10M28.10M
selling general and administrative expenses95.564M103.554M98.97M86.809M83.188M
other expenses17.997M3.75M177.00K50.705M1.427M
operating expenses158.949M157.157M135.558M168.317M113.382M
cost and expenses167.386M165.212M143.686M175.695M119.914M
interest income0000757.00K
interest expense1.978M1.299M1.082M-10.69M-757.00K
depreciation and amortization2.061M1.993M1.831M-4.768M1.607M
ebitda-60.563M-78.046M-65.444M-117.71M-62.12M
ebitda ratio-0.578-0.895-0.891-1.646-1.075
operating income-62.624M-78.046M-68.687M-98.112M-62.12M
operating income ratio-0.598-0.895-0.916-1.372-1.075
total other income expenses net-1.978M-1.299M-1.082M-864.00K-757.00K
income before tax-64.602M-79.345M-68.357M-98.976M-62.877M
income before tax ratio-0.617-0.91-0.911-1.384-1.088
income tax expense001.00-3.601M678.00K
net income-64.602M-79.345M-68.357M-98.651M-62.199M
net income ratio-0.617-0.91-0.911-1.379-1.076
eps-1.34-1.67-1.44-2.08-1.32
eps diluted-1.34-1.67-1.44-2.08-1.32
weighted average shs out48.141M47.573M47.394M47.33M47.117M
weighted average shs out dil48.141M47.573M47.394M47.33M47.117M
Graph

AXSM Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents327.341M315.657M331.441M386.193M416.564M
short term investments00000
cash and short term investments327.341M315.657M331.441M386.193M416.564M
net receivables124.096M120.342M101.434M94.82M78.415M
inventory14.265M15.22M15.583M15.135M9.985M
other current assets13.411M11.808M12.032M8.115M6.799M
total current assets479.113M463.027M460.49M504.263M511.763M
property plant equipment net5.73M6.795M9.605M7.618M8.039M
goodwill12.042M12.042M12.042M12.042M12.042M
intangible assets48.501M50.107M51.697M53.286M54.893M
goodwill and intangible assets60.543M62.149M63.739M65.328M66.935M
long term investments00000
tax assets00000
other non current assets16.072M16.255M11.894M11.027M14.12M
total non current assets82.345M85.199M85.238M83.973M89.094M
other assets001.0000
total assets561.458M548.226M545.728M588.236M600.857M
account payables64.253M61.34M53.791M40.679M29.098M
short term debt2.907M2.616M1.785M1.267M438.00K
tax payables493.00K493.00K492.00K00
deferred revenue00492.00K078.454M
other current liabilities128.534M122.121M87.98M96.908M6.672M
total current liabilities196.187M186.57M144.048M138.854M114.662M
long term debt189.393M189.184M187.644M178.07M185.137M
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities82.98M69.62M70.00M80.335M31.55M
total non current liabilities272.373M258.804M257.644M258.405M216.687M
other liabilities0001.000
capital lease obligations12.298M12.47M8.955M7.035M8.129M
total liabilities468.56M445.374M401.692M397.259M331.349M
preferred stock00000
common stock5.00K5.00K5.00K5.00K5.00K
retained earnings-1.048B-983.273M-903.928M-835.571M-736.92M
accumulated other comprehensive income loss00000
other total stockholders equity1.141B1.086B1.048B1.027B1.006B
total stockholders equity92.898M102.852M144.036M190.977M269.508M
total equity92.898M102.852M144.036M190.977M269.508M
total liabilities and stockholders equity561.458M548.226M545.728M588.236M600.857M
minority interest00000
total investments00000
total debt192.30M191.80M189.429M186.372M185.575M
net debt-135.041M-123.857M-142.012M-199.821M-230.989M
Graph

AXSM Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
deferred income tax00-617.00K0617.00K
stock based compensation21.382M20.19M18.915M14.84M15.922M
change in working capital22.881M-6.807M3.425M-8.962M-13.228M
accounts receivables-18.907M-6.615M-16.405M-11.005M-22.617M
inventory690.00K-105.00K-4.888M2.806M-1.052M
accounts payables7.549M13.112M11.581M-13.86M7.188M
other working capital33.549M-13.199M13.137M13.097M3.253M
other non cash items38.875M17.136M44.826M1.03M7.135M
net cash provided by operating activities-30.11M-53.467M-30.362M-53.548M-55.349M
investments in property plant and equipment-52.00K-98.00K-7.00K-371.00K-133.00K
acquisitions net00000
purchases of investments00000
sales maturities of investments00000
other investing activites0-98.00K000
net cash used for investing activites-52.00K-98.00K-7.00K-371.00K-133.00K
debt repayment-186.00K-163.00K-855.00K-856.00K-29.776M
common stock issued17.78M2.501M1.145M33.75M225.00M
common stock repurchased-1.328M-1.618M0-355.00K-333.00K
dividends paid000-1.211M-29.443M
other financing activites-3.216M-3.525M-292.00K2.042M80.632M
net cash used provided by financing activities14.378M-1.187M-2.00K33.37M246.08M
effect of forex changes on cash00189.981M0-189.981M
net change in cash-15.784M-54.752M-30.371M-20.549M190.598M
cash at end of period315.657M331.441M386.193M416.564M437.113M
cash at beginning of period331.441M386.193M416.564M437.113M246.515M
operating cashflow-30.11M-53.467M-30.362M-53.548M-55.349M
capital expenditure-52.00K-98.00K-7.00K-371.00K-133.00K
free cash flow-30.162M-53.565M-30.369M-53.919M-55.482M
Graph

Frequently Asked Questions

How did Axsome Therapeutics, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, AXSM generated $104.76M in revenue last quarter, while its costs came in at $8.44M.

Last quarter, how much Gross Profit did Axsome Therapeutics, Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Axsome Therapeutics, Inc. reported a $96.33M Gross Profit for the quarter ended Jun 30, 2024.

Have AXSM's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. AXSM incurred $158.95M worth of Operating Expenses, while it generated -$62.62M worth of Operating Income.

How much Net Income has AXSM posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Axsome Therapeutics, Inc., the company generated -$64.60M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Axsome Therapeutics, Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Axsome Therapeutics, Inc. as of the end of the last quarter was $327.34M.

What are AXSM's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, AXSM had Total Net Receivables of $124.10M.

In terms of Total Assets and Current Assets, where did Axsome Therapeutics, Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of AXSM were $479.11M, while the Total Assets stand at $561.46M.

As of the last quarter, how much Total Debt did Axsome Therapeutics, Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of AXSM's debt was $192.30M at the end of the last quarter.

What were AXSM's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, AXSM reported total liabilities of $468.56M.

How much did AXSM's Working Capital change over the last quarter?

Working Capital Change for AXSM was $22.88M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

AXSM generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. AXSM generated -$30.11M of Cash from Operating Activities during its recently reported quarter.

What was AXSM's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. AXSM reported a -$15.78M Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph